Abstract
METHOD: We carry out an observational study where reviewed the PET/CT studies with PSMA marked with Fluor-18 (18F) carried out from February 2019 to September 2020. We analyzed the average value of hepatic uptake SUV lean average (SUVlave), acquisition time, age, reason from the study, focal, multifocal and diffuse prostate uptake, analysis of the location of metastases, level of prostate specific antigen (PSA), we describe uptakes of non-prostate origin and focal uptakes in ribs without anatomical representation. RESULTS: The average hepatic SUVlave was 9.7, the acquisition times were variable (52 - 183 minutes) without alterations in the white-background relationship, the most frequent indication for the study was staging, the uptake in ribs without anatomical representation were considered benign with certain characteristics, PET/CT has the ability to detect neoplastic activity with low PSA levels in lymph nodes 18F-PSMA has advantages over bone scan and computed tomography of the abdomen and pelvis for the staging of prostate cancer.
Highlights
Prostate cancer is a malignant neoplasm that occurs in older men [1]
We analyzed the average value of hepatic uptake SUV lean average (SUVlave), acquisition time, age, reason from the study, focal, multifocal and diffuse prostate uptake, analysis of the location of metastases, level of prostate specific antigen (PSA), we describe uptakes of non-prostate origin and focal uptakes in ribs without anatomical representation
The objective of this study is to evaluate the results obtained in the scans carried out with PET/CT with 18F-Prostate Specific Membrane Antigen (PSMA) during the period: February 2019 to September 2020
Summary
Prostate cancer is a malignant neoplasm that occurs in older men [1]. In Mexico, it ranks second in causes of death from cancer, after lung [2]. Since most of the prostate cancer diagnosis appears in men over 64 years of age, first-degree family history, black African-American. The diagnosis is determined by the prostate specific antigen (PSA), the Gleason score and the extent of the tumor. Various imaging methods are used for initial staging. Magnetic resonance imaging (MRI) shows promising results in locating the tumor and improves the precision of ultrasound-guided biopsy [4], despite the fact that European guidelines recommend the use of magnetic resonance imaging in the event that the tumor does not affect other organs, the images suffer from a certain limitation, especially in the central and transition areas [5] [6]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
